DSO Acquisition Due Diligence: The Operational Checklist PE Sponsors Miss

Every private equity sponsor evaluating a dental services organization (DSO) platform or add-on knows how to run financial diligence. Quality of earnings reports get commissioned. Add-back schedules get scrutinized line by line. EBITDA multiples get benchmarked against comparable transactions. But a disproportionate share of post-close value destruction in DSO deals doesn't originate in the financials — it originates in the operations that the financials were built on top of.

A quality of earnings (QoE) report tells you what a practice earned. It rarely tells you why it earned it, whether that earnings capacity is fragile or durable, or what it will cost to integrate that practice into a platform without breaking the thing that made it profitable in the first place. That gap between financial diligence and operational diligence is where DSO deals quietly underperform their models — not because the multiple was wrong, but because the operating assumptions baked into the pro forma were never stress-tested against how the practice actually runs day to day.

This is the operational due diligence checklist that closes that gap. It's written for PE sponsors evaluating a DSO platform investment or add-on acquisition, and for DSO operators building or refining their own diligence playbook ahead of a roll-up strategy.

Why Operational Diligence Gets Shortchanged

Operational diligence is harder to standardize than financial diligence, and it's harder to outsource. A QoE provider can run the same revenue recognition and add-back methodology across every deal in a sponsor's pipeline. Operational diligence requires someone who has actually run a dental practice or a DSO platform to sit with the clinical schedule, the hygiene reappointment rate, the associate compensation model, and the practice management system (PMS) configuration and ask whether what they're looking at is sustainable or artificially inflated for the sale.

There's also a timeline problem. Most DSO transactions run on compressed diligence windows — often 30 to 60 days from LOI to close — and operational diligence tends to get compressed into whatever time is left after financial and legal workstreams are satisfied. That sequencing is backwards. Operational findings frequently change the deal thesis, the purchase price, or the structure of the transition services agreement, so they need to run in parallel with financial diligence, not after it.

Sponsors who treat operational diligence as a confirmatory exercise rather than a value-driving one are the ones most likely to discover, six to twelve months post-close, that the practice's production capacity was overstated, the associate they were counting on to anchor a satellite location has already resigned, or the PMS data they underwrote the deal on doesn't reconcile with what's actually in the system.

The Operational Checklist

1. Clinical Production Capacity and Provider Dependency

Financial diligence looks at collections. Operational diligence looks at what's actually generating those collections and how fragile that generation is.

Provider-level production concentration. What percentage of total production sits with the founding dentist or a single associate? A practice where one provider generates 60%+ of production carries key-person risk that a multiple of trailing EBITDA doesn't price in on its own.
Chair utilization and schedule density. Pull actual schedule utilization by operatory and by day, not the practice's self-reported "we're at capacity" claim. Open chair time hiding behind a fully-booked front desk is a common finding.
Hygiene department health. Hygiene reappointment rate, hygiene-to-doctor production ratio, and perio program penetration are leading indicators of both patient retention and near-term production stability. A weak hygiene department is one of the more reliable predictors of production decline in year one post-close.
Case acceptance and treatment plan aging. What's sitting in unscheduled treatment, and how old is it? A large unscheduled treatment plan balance can look like upside in a pitch deck and turn out to be treatment the patient already declined twice.
Specialty referral leakage. For practices being underwritten with in-house specialty expansion (ortho, oral surgery, endo) as part of the value creation thesis, quantify what's currently being referred out and to whom. This determines whether the expansion thesis is additive or whether it requires displacing an established referral relationship the patient may not want disrupted.

2. Revenue Cycle Management and Billing Infrastructure

RCM is where operational and financial diligence should overlap most closely, and where sponsors most often rely too heavily on top-line collections figures without opening up the underlying process.

Days in accounts receivable, aged by payer type. Fee-for-service, PPO, and Medicaid/CHIP receivables age differently and carry different collectability risk. A blended AR days figure can mask a payer mix problem.
Claim denial rate and resubmission workflow. High first-pass denial rates point to coding, documentation, or eligibility-verification gaps that will follow the practice into the platform's centralized RCM function and dilute the efficiency the platform was supposed to deliver.
In-network vs. out-of-network fee schedule exposure. Confirm which payer contracts transfer with the entity versus which are held at the individual provider level and may not survive a change of ownership or a provider's departure.
Write-off and adjustment patterns. Look for unusual spikes in adjustments in the months immediately preceding the sale process — a common lever for smoothing collections optics ahead of a QoE engagement.
PMS-to-clearinghouse reconciliation. Confirm that what's in the practice management system actually reconciles with bank deposits and clearinghouse remittance data. Discrepancies here are a red flag for both revenue quality and data integrity going into platform integration.

3. Technology Stack, PMS, and Data Portability

A practice's technology stack is one of the most underweighted line items in DSO due diligence, and one of the most expensive to underestimate.

PMS platform and version. Confirm which practice management system is in use (Dentrix, Eaglesoft, Open Dental, Denticon, and so on) and whether it matches — or can be migrated to — the platform's target-state system. Migration cost and clinical/administrative disruption scale significantly depending on the source system.
Data cleanliness and migration risk. Duplicate patient records, incomplete perio chartings, and inconsistent procedure coding all increase migration cost and delay the timeline for centralizing reporting across the platform.
Imaging and integration architecture. Confirm how digital imaging, intraoral scanners, and any AI-assisted diagnostic tools integrate with the PMS, and whether licenses are practice-owned, provider-owned, or tied to a vendor contract that doesn't transfer cleanly at close.
Cybersecurity and HIPAA posture. Request the practice's most recent risk assessment, breach history, and business associate agreement inventory. A gap here is both an operational liability and, increasingly, a component of representations and warranties negotiations.

4. Labor, Compensation Structure, and Retention Risk

Labor is the single largest controllable cost in a dental practice, and it's also the area most likely to move unpredictably post-close if diligence doesn't dig into structure, not just headcount.

Associate and hygienist compensation methodology. Percentage-of-production, percentage-of-collections, guaranteed base, or hybrid — each carries different incentive alignment and different retention risk once the practice moves to a platform compensation model.
Non-compete and non-solicit enforceability. Confirm which restrictive covenants are actually enforceable in the practice's state and whether they survive the transaction structure being used. Several states have narrowed non-compete enforceability meaningfully in recent years, and a covenant that looked protective in the CIM may not hold up.
Staff tenure and turnover history. Front desk and clinical staff turnover in the 12 months pre-sale is a strong predictor of post-close disruption, particularly for patient scheduling continuity and case acceptance, both of which depend heavily on staff relationships with patients.
Retention agreement structure for key clinical staff. Confirm whether retention bonuses or earnout-linked compensation exist for the selling dentist and any associates, and understand how those incentives are structured to avoid a cliff-edge departure once the retention period lapses.

5. Supply Chain, Vendor Contracts, and Group Purchasing Leverage

Dental supply and lab contracts. Identify contract terms, exclusivity clauses, and termination rights for dental supply distributors and outsourced lab relationships. Platform-level GPO (group purchasing organization) synergies are a common part of the DSO value creation thesis, and contracts with long remaining terms or unfavorable termination provisions can delay realizing that synergy by a year or more.
Equipment leases and capital equipment condition. Confirm remaining useful life and lease terms on CBCT units, chairs, sterilization equipment, and any CAD/CAM systems. Equipment that requires near-term capex replacement should be reflected in the deal model, not discovered in month three.
Facilities and lease terms. Review remaining lease term, renewal options, assignment/change-of-control clauses, and co-tenancy or exclusivity provisions that could constrain future satellite or de novo expansion in the same market.

6. Multi-Site Standardization and SOP Maturity

For platforms acquiring beyond a single location, or for add-ons being folded into an existing platform, standardization maturity is a direct driver of integration cost and timeline.

Documented SOPs vs. tribal knowledge. Confirm whether clinical protocols, new patient intake, and scheduling templates are documented or exist only in the practice manager's head. Undocumented process is the single biggest driver of integration timeline slippage.
Cross-location consistency (for existing multi-site sellers). Where the target already operates multiple locations, check whether KPIs, fee schedules, and clinical protocols are actually standardized across sites or whether each location operates as an independent fiefdom under a shared brand.
Reporting cadence and KPI infrastructure. Determine what operational KPIs the practice currently tracks (new patient count, hygiene reappointment rate, case acceptance rate, no-show rate, provider production per day) and at what frequency. A seller with mature KPI infrastructure is both lower integration risk and a more reliable source for the trailing performance data the deal was underwritten on.

7. Regulatory, Compliance, and Corporate Practice of Dentistry Structure

Corporate Practice of Dentistry (CPOD) compliance. Confirm the management services organization (MSO) structure, the service agreement terms between the MSO and the dental practice entity, and that the arrangement complies with the specific state's CPOD restrictions. CPOD enforcement and MSO scrutiny have intensified in several states, and structures that were acceptable five years ago may not withstand current scrutiny.
Licensure and credentialing status. Confirm all provider licenses, DEA registrations, and payer credentialing are current and, critically, whether credentialing is held at the individual provider level in a way that could delay claims processing after a change of ownership.
State-specific dental board and insurance filings. Change-of-ownership notification requirements vary by state and, if missed, can create claims processing gaps and compliance exposure in the first 90 days post-close.

Sequencing Diligence With the Transition Services Agreement

One of the more consistent mistakes in DSO deal execution is treating the transition services agreement as a legal formality rather than an operational document. The TSA should be drafted using the specific findings from the operational checklist above, not a generic template reused across every add-on in the pipeline.

If the diligence process surfaces a PMS migration that will take longer than the standard 90-day window the platform typically budgets, the TSA needs to reflect that reality — including who owns data entry and reconciliation during the extended period, and what happens to reporting continuity in the interim. If the selling dentist is staying on for a defined transition period, the TSA should specify not just compensation during that window but also decision rights: who controls hiring, scheduling changes, and fee schedule adjustments while the seller is still clinically active but the platform has taken operational control.

A well-constructed TSA, built directly from operational diligence findings, does two things a generic template can't. First, it assigns clear ownership for every open item identified during diligence, so nothing that surfaced in week three of the process quietly falls through the cracks between signing and close. Second, it gives the integration team a head start — rather than discovering the PMS data quality issue or the hygiene department staffing gap on day one of ownership, the integration team walks in with a prioritized list and an assigned owner for each item.

Building the Findings Into the Deal

Operational due diligence findings should feed directly into three parts of the transaction: the purchase price and structure, the transition services agreement (TSA), and the first-100-days integration plan. A finding that hygiene reappointment rates have been declining for six consecutive months, for example, isn't just a diligence note — it's an input into the earnout structure, the retention agreement for the hygiene team, and the integration plan's first-quarter priorities.

The sponsors who get the most value out of this checklist treat it as a live document that gets updated through close, not a one-time gate to clear before signing. Operational findings discovered in the final two weeks of diligence should still change deal terms — a compressed timeline is a reason to prioritize, not a reason to skip steps.

Red Flags That Should Pause a Deal

A handful of findings are severe enough that they warrant pausing the process rather than simply adjusting price:

Production concentration above roughly 70% in a single provider with no credible succession or retention plan
Undisclosed or unresolved CPOD compliance gaps in the practice's state
A pattern of AR write-offs or adjustments spiking in the months immediately before the sale process began
PMS data that doesn't reconcile against bank deposits or clearinghouse remittances
Non-compete or non-solicit language that is unenforceable in the practice's state, where retention of the selling provider is central to the deal thesis

None of these are automatically deal-killers, but each one requires a specific mitigant — price adjustment, escrow, retention structure, or a defined remediation plan — before close, not a general assumption that the platform's integration team will "figure it out" afterward.

Frequently Asked Questions

What's the difference between financial due diligence and operational due diligence in a DSO acquisition?
Financial due diligence, typically delivered as a quality of earnings report, validates what a practice has historically earned and normalizes that earnings figure for one-time items and owner add-backs. Operational due diligence evaluates the underlying clinical, technological, staffing, and compliance systems that produced those earnings, and assesses how durable that earnings capacity is once the practice is integrated into a platform.

How long should operational due diligence take in a DSO transaction?
Operational diligence should run in parallel with financial and legal diligence, not sequentially after it, ideally starting at LOI. For a single-location add-on, a focused operational assessment can typically be completed in two to three weeks. Multi-site platforms or complex CPOD structures generally require four to six weeks to properly assess standardization maturity across locations.

What is Corporate Practice of Dentistry (CPOD) risk, and why does it matter for PE sponsors?
CPOD laws in most states restrict non-dentists from owning or controlling a dental practice, which is why DSO transactions are typically structured through a management services organization (MSO) that provides administrative services to a dentist-owned practice entity. Sponsors need to confirm that the specific MSO service agreement, fee structure, and governance terms comply with the target state's CPOD restrictions, since enforcement and scrutiny of these arrangements have increased in a number of states.

What operational metrics matter most when evaluating a DSO acquisition target?
Hygiene reappointment rate, case acceptance rate, provider-level production concentration, new patient count trend, and days in accounts receivable by payer type are among the most predictive operational metrics for assessing the durability of a target's earnings and the near-term integration risk.

How does provider dependency affect DSO deal valuation?
A practice where a single provider generates a disproportionate share of production carries key-person risk that isn't fully captured in a trailing EBITDA multiple. Sponsors typically address this through retention agreements, earnout structures tied to the provider's continued involvement, or a discounted purchase price that reflects the probability and cost of replacing that production capacity.

Should PE sponsors bring in outside operational diligence expertise, or can internal deal teams handle it?
Internal deal teams are generally well-equipped to run financial and legal diligence workstreams, but few have someone on staff who has operated a dental practice or DSO platform day to day. Bringing in dental-specific operational expertise, either as a dedicated diligence workstream or embedded within the broader diligence process, tends to surface findings that a generalist deal team or a standard QoE engagement will miss.

The Bottom Line

The financial due diligence process in DSO transactions has become highly standardized — QoE providers, legal counsel, and deal structures have converged on a common playbook. Operational due diligence hasn't converged the same way, which means it remains one of the few places where a sponsor's diligence process can be a genuine source of competitive advantage in a crowded DSO M&A market, rather than a compliance exercise.

The checklist above isn't exhaustive for every deal — a single-location add-on and a 40-location platform recapitalization warrant different depth in different areas. But the underlying discipline is the same: treat operational diligence as a parallel, value-driving workstream from LOI forward, not a confirmatory step squeezed into the final week before close. The sponsors who do this consistently are the ones whose post-close performance actually tracks their underwriting model.